IsoPlexis, Lonza partner on cell therapy manufacturing

By The Science Advisory Board staff writers

August 20, 2020 -- IsoPlexis and Lonza have partnered to advance automated cell therapy manufacturing.

The partnership will utilize IsoPlexis' IsoLight automated cell manufacturing platform and Lonza's Cocoon automated cell therapy manufacturing solution to perform end-to-end automation. Notably, IsoLight will perform functional proteomics analysis on cell therapy products created by Cocoon.

IsoLight provides functional characterization of cell therapy products for correlative functional potency, according to IsoPlexis. Meanwhile, Cocoon enables centralized and decentralized manufacturing of novel cell therapies, noted Lonza.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.